These mechanisms are highly conserved across multiple cancer types, including ICC, GC, HCC, NSCLC, CRC, MM, PC, OSCC, LUSC, and NPC, highlighting the potential of METTL5 as a diagnostic biomarker and therapeutic target. The gene discussed is METTL5; the disease is cancer.